CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Cardiol Therapeutics Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026
$1.10+0.00 (0.00%)
Close on Oct 19, 2026
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
29.4%
29M of 100M shares
Institutional holders
52
12 new, 6 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Tejara Capital Ltd | 6,382,551 | 5.30% | 13G (passive) amendment | Sep 2, 2026 |
| MM Asset Management Inc. | 21,310,099 | 17.60% | 13G (passive) amendment | Jun 30, 2026 |
| MMCAP International Inc. SPC | 21,063,856 | 17.90% | 13G (passive) amendment | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CRDL | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 15,598,560 | 15.56% | $16.53M | +246,243 | 1.40% |
| Tejara Capital Ltd | 5,113,822 | 5.10% | $5.42M | −16,300 | 2.23% |
| Ikarian Capital, LLC | 3,325,000 | 3.32% | $3.52M | +600,000 | 0.38% |
| Boothbay Fund Management, LLC | 975,721 | 0.97% | $1.03M | +180,840 | 0.01% |
| Citadel Advisors LLC | 796,529 | 0.79% | $844.32K | −23,375 | 0.00% |
| Renaissance Technologies LLC | 772,837 | 0.77% | $819.21K | +543,031 | 0.00% |
| Two Sigma Investments, LP | 746,937 | 0.75% | $791.75K | +212,726 | 0.00% |
| Integrity Alliance, LLC. | 388,492 | 0.39% | $411.80K | −76,533 | 0.01% |
| Morgan Stanley | 355,030 | 0.35% | $376.33K | +104,609 | 0.00% |
| Goldman Sachs Group Inc | 333,900 | 0.33% | $353.93K | +1,500 | 0.00% |
| Pvg Asset Management Corp | 107,165 | 0.11% | $113.60K | – | 0.07% |
| Mgo One Seven LLC | 100,000 | 0.10% | $106.00K | – | 0.00% |
| 1832 Asset Management L.P. | 100,000 | 0.10% | $106.00K | – | 0.00% |
| Summit Financial, LLC | 99,109 | 0.10% | $105.06K | −4,950 | 0.00% |
| Jane Street Group, LLC | 53,416 | 0.05% | $56.07K | −73,541 | 0.00% |
| JPMorgan Chase & Co | 48,077 | 0.05% | $49.52K | – | 0.00% |
| Hrt Financial LP | 47,179 | 0.05% | $50 | New | 0.00% |
| Acadian Asset Management LLC | 44,255 | 0.04% | $45 | New | 0.00% |
| Geode Capital Management, LLC | 42,196 | 0.04% | $44.73K | −10,239 | 0.00% |
| Marble Harbor Investment Counsel, LLC | 39,900 | 0.04% | $42.29K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 52 | 29M | 29.4% | 12 / 11 | 10 / 6 | 2M | 0M |
| Q1 2026 | 47 | 28M | 27.8% | 15 / 9 | 6 / 9 | 20M | 1M |
| Q4 2025 | 41 | 9M | 9.1% | 9 / 11 | 12 / 14 | 4M | 2M |
| Q3 2025 | 48 | 7M | 7.3% | 17 / 4 | 13 / 7 | 3M | 2M |
| Q2 2025 | 38 | 6M | 6.5% | 7 / 9 | 11 / 7 | 0M | 2M |
| Q1 2025 | 38 | 8M | 7.7% | 4 / 14 | 9 / 9 | 1M | 0M |
| Q4 2024 | 43 | 7M | 7.5% | 13 / 11 | 6 / 11 | 3M | 1M |
| Q3 2024 | 41 | 5M | 5.0% | 10 / 6 | 10 / 9 | 0M | 1M |
| Q2 2024 | 41 | 5M | 5.4% | 12 / 10 | 6 / 5 | 1M | 2M |
| Q1 2024 | 35 | 7M | 6.5% | 6 / 4 | 7 / 3 | 1M | 1M |
| Q4 2023 | 32 | 7M | 6.9% | 3 / 5 | 5 / 6 | 1M | 0M |
| Q3 2023 | 35 | 6M | 6.4% | 8 / 8 | 3 / 6 | 0M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CRDL | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund | 60,699 | 0.06% | $74.05K | 0.00% | May 31, 2026 |